BR112015022770A2 - métodos e materiais para diferenciação hematoendotelial de células-tronco pluripotentes humanas sob condições definidas - Google Patents
métodos e materiais para diferenciação hematoendotelial de células-tronco pluripotentes humanas sob condições definidasInfo
- Publication number
- BR112015022770A2 BR112015022770A2 BR112015022770A BR112015022770A BR112015022770A2 BR 112015022770 A2 BR112015022770 A2 BR 112015022770A2 BR 112015022770 A BR112015022770 A BR 112015022770A BR 112015022770 A BR112015022770 A BR 112015022770A BR 112015022770 A2 BR112015022770 A2 BR 112015022770A2
- Authority
- BR
- Brazil
- Prior art keywords
- stem cells
- pluripotent stem
- methods
- human pluripotent
- materials
- Prior art date
Links
- 210000001778 pluripotent stem cell Anatomy 0.000 title abstract 6
- 230000004069 differentiation Effects 0.000 title abstract 3
- 239000000463 material Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 230000003511 endothelial effect Effects 0.000 abstract 2
- 230000003394 haemopoietic effect Effects 0.000 abstract 2
- 102000005606 Activins Human genes 0.000 abstract 1
- 108010059616 Activins Proteins 0.000 abstract 1
- 101150063837 Aplnr gene Proteins 0.000 abstract 1
- 101150019331 FGF2 gene Proteins 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 239000000488 activin Substances 0.000 abstract 1
- 101150067309 bmp4 gene Proteins 0.000 abstract 1
- YSFTYXKQUONNFY-NQXPEFQPSA-N fgf2 Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 YSFTYXKQUONNFY-NQXPEFQPSA-N 0.000 abstract 1
- 230000001146 hypoxic effect Effects 0.000 abstract 1
- 210000001704 mesoblast Anatomy 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0056—Xeno-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0695—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
abstract methods and compositions for differentiating pluripotent stem cells into cells of endothelial and hematopoietic lineages are disclosed. tradução do resumo resumo patente de invenção: "métodos e materiais para diferenciação hematoendotelial de células-tronco pluripotentes humanas sob condições definidas". o presente pedido de patente refere-se a métodos e composições para a diferenciação de células tronco pluripotentes para células de linhagens hematopoiéticas e endoteliais são divulgados. particularmente, refere-se a um método de diferenciação de células tronco pluripotentes humanas, compreendendo as etapas de (a) forncecer células tronco pluripotentes humanas; e (b) expor as células tronco a uma mistura compreendendo componentes fgf2, bmp4, activina a, e licl, sob condições hipóxicas durante um período de cerca de dois dias de modo a formar uma população de células da mesoderme primitivas emhlin- kdr+aplnr+pdgfralpha+ com potencial mesenquimoangioblasto.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361779564P | 2013-03-13 | 2013-03-13 | |
US61/779,564 | 2013-03-13 | ||
PCT/US2014/024518 WO2014165131A1 (en) | 2013-03-13 | 2014-03-12 | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112015022770A2 true BR112015022770A2 (pt) | 2017-07-18 |
BR112015022770A8 BR112015022770A8 (pt) | 2019-11-26 |
BR112015022770B1 BR112015022770B1 (pt) | 2022-11-16 |
Family
ID=50678273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015022770-8A BR112015022770B1 (pt) | 2013-03-13 | 2014-03-12 | Meio e sistema de cultivo da célula livre de xenógeno, livre de albumina, forma concentrada, métodos de diferenciação de células-tronco pluripotentes humanas, para a produção de mesenquimoangioblastos e sistema definido de cultivo da célula para diferenciação hematoendotelial das células- tronco pluripotentes humanas |
Country Status (19)
Country | Link |
---|---|
US (3) | US9938499B2 (pt) |
EP (1) | EP2970912B1 (pt) |
JP (1) | JP6677631B2 (pt) |
KR (1) | KR102151210B1 (pt) |
CN (1) | CN105209609B (pt) |
AU (1) | AU2014248651B2 (pt) |
BR (1) | BR112015022770B1 (pt) |
CA (2) | CA2905786C (pt) |
DK (1) | DK2970912T3 (pt) |
ES (1) | ES2720196T3 (pt) |
HK (1) | HK1218927A1 (pt) |
HU (1) | HUE043785T2 (pt) |
IL (1) | IL241286B (pt) |
MX (1) | MX366900B (pt) |
PL (1) | PL2970912T3 (pt) |
PT (1) | PT2970912T (pt) |
SG (1) | SG11201507275TA (pt) |
TR (1) | TR201904270T4 (pt) |
WO (1) | WO2014165131A1 (pt) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2377924A1 (en) | 2006-04-14 | 2011-10-19 | Advanced Cell Technology, Inc. | Hemangio-colony forming cells |
US9719068B2 (en) | 2010-05-06 | 2017-08-01 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into intestinal tissues through directed differentiation |
US9868939B2 (en) | 2013-06-12 | 2018-01-16 | Wisconsin Alumni Research Foundation | Generating vasculogenic cell populations |
US10174289B2 (en) | 2014-05-28 | 2019-01-08 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into gastric tissues through directed differentiation |
WO2016061464A1 (en) | 2014-10-17 | 2016-04-21 | Children's Hospital Center, D/B/A Cincinnati Children's Hospital Medical Center | In vivo model of human small intetine using pluripotent stem cells and methods of making and using same |
US11220672B2 (en) * | 2014-12-31 | 2022-01-11 | Wisconsin Alumni Research Foundation | Human pluripotent stem cell-based system for generating endothelial cells |
US10626372B1 (en) * | 2015-01-26 | 2020-04-21 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
BR112017017886B1 (pt) | 2015-02-20 | 2024-02-06 | Wisconsin Alumni Research Foundation | Método para obter células endoteliais arteriais humanas, populações isoladas puras de células endoteliais arteriais, método de rastreio de um agente in vitro, método in vitro para vascularizar um construto de tecido engenheirado, uso das referidas células e composição farmacêutica compreendendo as referidas células |
US10787640B2 (en) | 2015-03-03 | 2020-09-29 | The Board Of Trustees Of The Leland Stanford Junior University | Producing mesodermal cell types and methods of using the same |
CN104660703B (zh) * | 2015-03-05 | 2017-12-15 | 国家电网公司 | 多网络融合用电信息采集系统及最优通信网络的选择方法 |
JP6773268B2 (ja) * | 2015-03-09 | 2020-10-21 | 学校法人慶應義塾 | 多能性幹細胞を所望の細胞型へ分化する方法 |
EP3313434A4 (en) * | 2015-06-29 | 2019-03-27 | Northeastern University | GENERATOR OF DENDRITIC CELLS |
JP6646311B2 (ja) * | 2015-07-17 | 2020-02-14 | 国立大学法人京都大学 | 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法 |
WO2017070337A1 (en) * | 2015-10-20 | 2017-04-27 | Cellular Dynamics International, Inc. | Methods for directed differentiation of pluripotent stem cells to immune cells |
US10858628B2 (en) | 2015-11-04 | 2020-12-08 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
CN108368520B (zh) | 2015-11-04 | 2023-01-17 | 菲特治疗公司 | 多能细胞的基因组工程改造 |
CN108884441B (zh) * | 2016-03-16 | 2022-05-06 | 洋蓟治疗有限公司 | 集落形成培养基及其用途 |
WO2017181168A1 (en) * | 2016-04-15 | 2017-10-19 | Angiocrine Bioscience, Inc. | Enhanced gene delivery methods |
US11066650B2 (en) | 2016-05-05 | 2021-07-20 | Children's Hospital Medical Center | Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same |
WO2017200486A1 (en) * | 2016-05-17 | 2017-11-23 | Agency For Science, Technology And Research | Human stem cell derived endothelial cells, endothelial- hepatocyte co-culture system and uses thereof |
WO2018037091A1 (en) * | 2016-08-24 | 2018-03-01 | Hi-Stem Ggmbh | Methods for the identification and isolation of hematopoietic stem and progenitor cells |
EP3510145A4 (en) | 2016-09-06 | 2020-03-25 | The Children's Medical Center Corporation | IMMUNCELLS FROM INDUCED PLURIPOTENT STEM CELLS |
CN110050061A (zh) | 2016-10-05 | 2019-07-23 | 富士胶片细胞动力公司 | 从具有MeCP2破坏的诱导多能干细胞生成成熟谱系 |
JP7212615B2 (ja) * | 2016-10-05 | 2023-01-25 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法 |
AU2017373767B2 (en) | 2016-12-05 | 2021-09-16 | Children's Hospital Medical Center | Colonic organoids and methods of making and using same |
EP3601540A1 (en) * | 2017-03-21 | 2020-02-05 | Etablissement Français du Sang | Methods of improving hematopoietic grafts |
CN106867961A (zh) * | 2017-03-27 | 2017-06-20 | 广州润虹医药科技有限公司 | 一种诱导多能干细胞形成中胚层细胞的诱导培养基及诱导方法 |
EP3606540A1 (en) * | 2017-04-07 | 2020-02-12 | Cynata Therapeutics Limited | Method for treating a side effect of chimeric antigen receptor (car) t cell therapy |
WO2018227244A1 (en) * | 2017-06-16 | 2018-12-20 | Cynata Therapeutics Limited | Method for treating a side effect of immunotherapy |
WO2018229251A1 (en) * | 2017-06-16 | 2018-12-20 | Imba - Institut Für Molekulare Biotechnologie Gmbh | Blood vessel organoid, methods of producing and using said organoids |
EP3679124A1 (en) * | 2017-09-07 | 2020-07-15 | Stemonix Inc. | Efficient differentiation of human stem cells to definitive endoderm |
US11471493B2 (en) | 2017-09-15 | 2022-10-18 | Cynata Therapeutics Limited | Method for treating allergic airways disease (AAD)/asthma |
CA3084575A1 (en) | 2017-11-22 | 2019-05-31 | Mesoblast International Sarl | Cellular compositions and methods of treatment i |
WO2019126146A1 (en) | 2017-12-19 | 2019-06-27 | Xcell Biosciences, Inc. | Methods of modulating cell phenotype by way of regulating the gaseous environment |
BR112020013656A2 (pt) * | 2018-01-05 | 2020-12-01 | Platelet Biogenesis, Inc. | composições e métodos para produção de megacariócitos |
EP3847243A1 (en) * | 2018-09-07 | 2021-07-14 | Wisconsin Alumni Research Foundation | Generation of hematopoietic progenitor cells from human pluripotent stem cells |
CN109334379B (zh) * | 2018-09-19 | 2021-11-23 | 江苏大学 | 重型车用液电式惯容器非线性惯性力辨识方法 |
US10647954B1 (en) | 2018-11-15 | 2020-05-12 | Flaskworks, Llc | Dendritic cell generating apparatus and method |
WO2020154412A1 (en) * | 2019-01-22 | 2020-07-30 | Washington University | Compositions and methods for generating hematopoietic stem cells (hscs) |
CN109652369B (zh) * | 2019-02-28 | 2020-01-03 | 西湖生物医药科技(杭州)有限公司 | 利用外周血体外制备成熟红细胞的方法及制剂 |
WO2021024207A1 (en) | 2019-08-05 | 2021-02-11 | Mesoblast International Sarl | Cellular compositions comprising viral vectors and methods of treatment |
US11566217B2 (en) | 2019-08-13 | 2023-01-31 | Flaskworks, Llc | Duty cycle for cell culture systems |
US20220275335A1 (en) * | 2019-08-20 | 2022-09-01 | Adaptimmune Limited | Culture medium for haematopoietic induction |
GB201911953D0 (en) * | 2019-08-20 | 2019-10-02 | Adaptimmune Ltd | T cell production fram RAG inacivated iPSCs |
GB201911957D0 (en) * | 2019-08-20 | 2019-10-02 | Adaptimmune Ltd | Methods of producing haemogenic progenitor cells from pluripotent stem cells |
WO2021080847A1 (en) | 2019-10-21 | 2021-04-29 | Flaskworks, Llc | Systems and methods for cell culturing |
JPWO2021085462A1 (pt) * | 2019-10-29 | 2021-05-06 | ||
WO2021126841A1 (en) * | 2019-12-16 | 2021-06-24 | The Board Of Trustees Of The Leland Stanford Junior University | Use of polyvinyl alcohol for cell culture of immune cells |
JP7072756B2 (ja) * | 2019-12-27 | 2022-05-23 | 国立大学法人京都大学 | 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法 |
CN113493767B (zh) * | 2020-04-01 | 2024-04-26 | 北京大学 | 利用人多潜能干细胞体外制备嗜酸性粒细胞 |
CN115996735A (zh) | 2020-08-10 | 2023-04-21 | 迈索布拉斯特国际有限公司 | 细胞组合物和治疗方法 |
CA3190402A1 (en) * | 2020-08-25 | 2022-03-03 | Gordon Keller | Compositions and methods for generating human yolk sac-like hematopoietic cells |
US11591381B2 (en) | 2020-11-30 | 2023-02-28 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
WO2022144632A1 (en) | 2020-12-30 | 2022-07-07 | Crispr Therapeutics Ag | Compositions and methods for differentiating stem cells into nk cells |
CN112680410B (zh) * | 2021-01-19 | 2022-08-02 | 上海爱萨尔生物科技有限公司 | 诱导多能干细胞分化培养心脏成纤维细胞的方法及其培养液 |
KR20220113586A (ko) * | 2021-02-05 | 2022-08-16 | 의료법인 성광의료재단 | 다능성 줄기세포 유래 조혈 내피세포를 이용한 유전자 편집된 세포의 제조방법 |
KR20220113290A (ko) * | 2021-02-05 | 2022-08-12 | 의료법인 성광의료재단 | 다능성 줄기세포 유래 조혈 내피세포로부터 림프구계세포의 분화 방법 |
GB202102297D0 (en) * | 2021-02-18 | 2021-04-07 | Adaptimmune Ltd | Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells |
CN113046318B (zh) * | 2021-04-13 | 2023-04-18 | 中国科学院深圳先进技术研究院 | 一种诱导多能干细胞向造血前体细胞分化的培养基以及方法 |
WO2023019213A1 (en) * | 2021-08-13 | 2023-02-16 | Simcere Innovation, Inc. | Three-dimensional culturing of pluripotent stem cells to produce hematopoietic stem cells |
WO2023201361A1 (en) | 2022-04-15 | 2023-10-19 | Aspen Neuroscience, Inc. | Methods of classifying the differentiation state of cells and related compositions of differentiated cells |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006029197A1 (en) | 2004-09-08 | 2006-03-16 | Wisconsin Alumni Research Foundation | Medium and culture of embryonic stem cells |
WO2006130651A2 (en) | 2005-06-01 | 2006-12-07 | Wisconsin Alumni Research Foundation | Method of forming dendritic cells from embryonic stem cells |
US8034613B2 (en) | 2005-06-01 | 2011-10-11 | Wisconsin Alumni Research Foundation | Multipotent lymphohematopoietic progenitor cells |
GB2449042B (en) | 2006-02-09 | 2010-07-07 | Wisconsin Alumni Res Found | Erythroid cells producing adult-type b-hemoglobin generated from human embryonic stem cells |
US8440461B2 (en) | 2007-03-23 | 2013-05-14 | Wisconsin Alumni Research Foundation | Reprogramming somatic cells using retroviral vectors comprising Oct-4 and Sox2 genes |
US20110236971A2 (en) | 2007-09-25 | 2011-09-29 | Maksym Vodyanyk | Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions |
US7615374B2 (en) | 2007-09-25 | 2009-11-10 | Wisconsin Alumni Research Foundation | Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions |
EP2229435B1 (en) | 2007-12-06 | 2016-03-02 | Agency for Science, Technology And Research | Method for extracellular matrix mediated differentiation and proliferation of stem cells |
EP3282010A1 (en) * | 2008-05-06 | 2018-02-14 | Astellas Institute for Regenerative Medicine | Methods for producing enucleated erythroid cells derived from pluripotent stem cells |
WO2010099539A1 (en) * | 2009-02-27 | 2010-09-02 | Cellular Dynamics International, Inc. | Differentiation of pluripotent cells |
WO2010143529A1 (ja) * | 2009-06-09 | 2010-12-16 | 国立大学法人名古屋大学 | 多能性幹細胞を胸腺上皮へ分化誘導する方法 |
EP2563908B1 (en) * | 2010-04-25 | 2019-01-09 | Icahn School of Medicine at Mount Sinai | Generation of anterior foregut endoderm from pluripotent cells |
US9279107B2 (en) | 2010-08-05 | 2016-03-08 | Wisconsin Alumni Research Foundation | Simplified basic media for human pluripotent cell culture |
-
2014
- 2014-03-12 CA CA2905786A patent/CA2905786C/en active Active
- 2014-03-12 JP JP2016501563A patent/JP6677631B2/ja active Active
- 2014-03-12 TR TR2019/04270T patent/TR201904270T4/tr unknown
- 2014-03-12 WO PCT/US2014/024518 patent/WO2014165131A1/en active Application Filing
- 2014-03-12 PT PT14722013T patent/PT2970912T/pt unknown
- 2014-03-12 CA CA3141731A patent/CA3141731A1/en active Pending
- 2014-03-12 MX MX2015012202A patent/MX366900B/es active IP Right Grant
- 2014-03-12 HU HUE14722013A patent/HUE043785T2/hu unknown
- 2014-03-12 BR BR112015022770-8A patent/BR112015022770B1/pt active IP Right Grant
- 2014-03-12 EP EP14722013.1A patent/EP2970912B1/en active Active
- 2014-03-12 US US14/206,778 patent/US9938499B2/en active Active
- 2014-03-12 ES ES14722013T patent/ES2720196T3/es active Active
- 2014-03-12 KR KR1020157028556A patent/KR102151210B1/ko active IP Right Grant
- 2014-03-12 SG SG11201507275TA patent/SG11201507275TA/en unknown
- 2014-03-12 PL PL14722013T patent/PL2970912T3/pl unknown
- 2014-03-12 AU AU2014248651A patent/AU2014248651B2/en active Active
- 2014-03-12 DK DK14722013.1T patent/DK2970912T3/en active
- 2014-03-12 CN CN201480027786.4A patent/CN105209609B/zh active Active
-
2015
- 2015-09-07 IL IL241286A patent/IL241286B/en active IP Right Grant
-
2016
- 2016-06-14 HK HK16106798.3A patent/HK1218927A1/zh unknown
-
2018
- 2018-03-09 US US15/917,504 patent/US20180258398A1/en not_active Abandoned
-
2022
- 2022-04-07 US US17/715,889 patent/US20220228118A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112015022770A8 (pt) | 2019-11-26 |
AU2014248651B2 (en) | 2019-01-17 |
BR112015022770B1 (pt) | 2022-11-16 |
MX366900B (es) | 2019-07-30 |
AU2014248651A1 (en) | 2015-10-01 |
SG11201507275TA (en) | 2015-10-29 |
JP6677631B2 (ja) | 2020-04-08 |
DK2970912T3 (en) | 2019-04-23 |
JP2016512031A (ja) | 2016-04-25 |
PT2970912T (pt) | 2019-05-31 |
TR201904270T4 (tr) | 2019-05-21 |
US20140273211A1 (en) | 2014-09-18 |
IL241286B (en) | 2020-03-31 |
EP2970912A1 (en) | 2016-01-20 |
HUE043785T2 (hu) | 2019-09-30 |
EP2970912B1 (en) | 2019-03-06 |
US9938499B2 (en) | 2018-04-10 |
ES2720196T3 (es) | 2019-07-18 |
CN105209609B (zh) | 2020-08-21 |
KR102151210B1 (ko) | 2020-09-02 |
WO2014165131A1 (en) | 2014-10-09 |
CN105209609A (zh) | 2015-12-30 |
MX2015012202A (es) | 2015-11-30 |
CA2905786A1 (en) | 2014-10-09 |
CA3141731A1 (en) | 2014-10-09 |
US20180258398A1 (en) | 2018-09-13 |
IL241286A0 (en) | 2015-11-30 |
HK1218927A1 (zh) | 2017-03-17 |
US20220228118A1 (en) | 2022-07-21 |
CA2905786C (en) | 2022-01-25 |
KR20150126943A (ko) | 2015-11-13 |
PL2970912T3 (pl) | 2019-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015022770A2 (pt) | métodos e materiais para diferenciação hematoendotelial de células-tronco pluripotentes humanas sob condições definidas | |
CR20210335A (es) | Compuestos de 2-formil-3-hidroxifeniloximetilo capaces de modular la hemoglobina | |
BR112017000313A2 (pt) | sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal | |
BR112015030946A8 (pt) | composição compreendendo uma célula ß pancreática não-nativa, método de diferenciação de células progenitoras em células ß pancreáticas in vitro e uso de uma célula ß pancreática não-nativa | |
BR112015020098A2 (pt) | método e composição para coloração e processamento de amostras | |
EA201692422A1 (ru) | Состав, содержащий пролекарство гемцитабина | |
EP2580320A4 (en) | REPROGRAMMING CELLS TO CONFERUE THEM WITH A NEW DESTINY | |
EA201001555A1 (ru) | Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17 | |
CR20180503A (es) | Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos | |
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
EP3943092A3 (en) | Compositions for use in inducing differentiation of human brown adipocyte progenitors | |
MX2015015409A (es) | Proceso para la preparacion de eritrocitos cargados con una o mas sustancias de interes farmaceutico y eritrocitos asi obtenidos. | |
CA2775299C (en) | Thrombin isolated from blood and blood fractions | |
BR112015009229A2 (pt) | composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada | |
BR112016020181A8 (pt) | composições de ácido lipoico éster colina e métodos de uso. | |
PH12017502112B1 (en) | Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors | |
PH12021551100A1 (en) | Dried biological compositions and methods thereof | |
WO2016176620A8 (en) | Extracellular matrix compositions for the treatment of cancer or immunological diseases | |
EA201690005A1 (ru) | Состав с модифицированной кинетикой высвобождения | |
RU2020111055A (ru) | Обогащение клетками, совместно экспрессирующими nkx6.1 и c-пептид, полученными in vitro из стволовых клеток | |
BR112015011764A2 (pt) | composições de baixo teor de sal de sódio e métodos de produção e utilização | |
BR112017009237A2 (pt) | composições de éster de forbol e métodos para tratar ou reduzir a duração de citopenia | |
PE20151085A1 (es) | Composicion de xantofilas | |
MX2016002930A (es) | Moduladores del receptor x hepatico (lxr). | |
WO2020097568A3 (en) | Oligosaccharide compositions and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/03/2014, OBSERVADAS AS CONDICOES LEGAIS |